SCHEMBL336314

SCHEMBL336314

C=C(CO)[C@H]1C/C=C(/C)CC/C=C(/C)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.57
ALOX15 P16050 3/20 0.41
CYP1B1 Q16678 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
CNR2 P34972 1/20 0.36
PPARA Q07869 1/20 0.36
TAS2R46 P59540 4/20 0.35
RECQL P46063 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TERT O14746 1/20 0.35
PKM P14618 1/20 0.35
PTPN1 P18031 1/20 0.34
TSHR P16473 1/20 0.34
TRPA1 O75762 1/20 0.34
STAT3 P40763 2/20 0.32
CYP3A4 P08684 2/20 0.32
MAPK1 P28482 1/20 0.32
CHRNA7 P36544 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL336313 1.00 LMNA (0.57) LMNAALOX15CYP1B1ALDH1A1MEN1
SCHEMBL1245213 0.93 LMNA (0.65) LMNAALOX15CYP1B1ALDH1A1MEN1
SCHEMBL20608601 0.93 LMNA (0.65) LMNAALOX15CYP1B1ALDH1A1MEN1
SCHEMBL20610540 0.93 LMNA (0.65) LMNAALOX15CYP1B1ALDH1A1MEN1
SCHEMBL23360385 0.81 LMNA (0.86) LMNAALOX15CYP1B1ALDH1A1MEN1
Cembrene_A SCHEMBL2041140 0.81 LMNA (0.86) LMNAALOX15CYP1B1ALDH1A1MEN1
Cembrene_A SCHEMBL11402150 0.81 LMNA (0.86) LMNAALOX15CYP1B1ALDH1A1MEN1
SCHEMBL31091157 0.81 LMNA (0.86) LMNAALOX15CYP1B1ALDH1A1MEN1
SCHEMBL23360384 0.81 LMNA (0.86) LMNAALOX15CYP1B1ALDH1A1MEN1
SCHEMBL31509123 0.81 LMNA (0.86) LMNAALOX15CYP1B1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230323314-A1 INCREASING PRODUCTIVITY OF E. COLI HOST CELLS THAT FUNCTIONALLY EXPRESS P450 ENZYMES SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT 2023-10-12 US disclosed
EP-3337893-B1 INCREASING PRODUCTIVITY OF E. COLI HOST CELLS THAT FUNCTIONALLY EXPRESS P450 ENZYMES MANUS BIO INC (US) 2023-07-19 EP disclosed
US-20230180691-A1 SECONDARY METABOLITE SCREENING SYSTEM MANUS BIO INC. 2023-06-15 US disclosed
EP-3183357-B1 METHOD FOR PRODUCING OXYGENATED VALENCENE MANUS BIO INC (US) 2020-03-04 EP disclosed
US-20190270971-A1 INCREASING PRODUCTIVITY OF MICROBIAL HOST CELLS THAT FUNCTIONALLY EXPRESS P450 ENZYMES MANUS BIO INC. 2019-09-05 US disclosed
US-9856460-B2 Nucleic acids encoding synthetic scaffolds and host cells genetically modified with the nucleic acids THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-01-02 US disclosed
EP-2489672-B1 Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof UNIV CALIFORNIA (US) 2017-01-18 EP disclosed
US-20140370595-A1 Use of Synthetic Scaffolds for the Production of Biosynthetic Pathway Products THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2014-12-18 US disclosed
US-8765403-B2 Use of synthetic scaffolds for the production of biosynthetic pathway products THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-07-01 US disclosed
US-8759632-B2 Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-06-24 US disclosed
US-8097438-B2 Nucleic acids encoding modified cytochrome P450 enzymes and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-17 US disclosed
US-20110008829-A1 Use of Synthetic Scaffolds for the Production of Biosynthetic Pathway Products THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2011-01-13 US disclosed
US-20100218283-A1 POLYNUCLEOTIDES ENCODING ISOPRENOID MODIFYING ENZYMES AND METHODS OF USE THEREOF EUAGORE, LLC 2010-08-26 US disclosed
US-20090098626-A1 NUCLEIC ACIDS ENCODING MODIFIED CYTOCHROME P450 ENZYMES AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-04-16 US disclosed
US-20080233623-A1 GENETICALLY MODIFIED HOST CELLS FOR INCREASED P450 ACTIVITY LEVELS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-09-25 US disclosed
US-20080124772-A1 Plant enzymes for bioconversion PLANT RESEARCH INTERNATIONAL B.V. 2008-05-29 US disclosed
EP-1916307-A1 Plant enzymes for bioconversion Plant Research International B.V. (NL) 2008-04-30 EP disclosed
US-20070300327-A1 Plant enzymes for bioconversion PLANT RESEARCH INTERNATIONAL B.V. 2007-12-27 US disclosed
US-7214507-B2 Plant enzymes for bioconversion PLANT RESEARCH INTERNATIONAL B.V. (NL) 2007-05-08 US disclosed
US-20050019882-A1 Using plant enzymes for the production of flavor, fragrance, pharmaceutical or bio-control agents from less valuable substrates; terpenoid biosynthesis STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080124772-A1 Plant enzymes for bioconversion STS, SQLE, CYP51A1 LMNA 2821/4885ALOX15 545/4885CYP1B1 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.